InMed Pharmaceuticals Inc (INM)
0.2701
-0.04
(-11.57%)
USD |
NASDAQ |
Apr 17, 14:52
InMed Pharmaceuticals Free Cash Flow (Quarterly): -1.857M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | -1.857M |
September 30, 2023 | -2.174M |
June 30, 2023 | -0.6915M |
March 31, 2023 | -1.785M |
December 31, 2022 | -2.713M |
September 30, 2022 | -2.256M |
June 30, 2022 | -4.047M |
March 31, 2022 | -5.352M |
December 31, 2021 | -3.569M |
September 30, 2021 | -2.654M |
June 30, 2021 | -2.006M |
March 31, 2021 | -4.612M |
December 31, 2020 | -1.801M |
September 30, 2020 | -1.372M |
June 30, 2020 | -1.398M |
March 31, 2020 | -1.530M |
December 31, 2019 | -2.092M |
September 30, 2019 | -2.398M |
June 30, 2019 | -1.928M |
March 31, 2019 | -2.143M |
December 31, 2018 | -1.300M |
September 30, 2018 | -1.335M |
June 30, 2018 | -0.9927M |
March 31, 2018 | -0.6884M |
December 31, 2017 | -0.8221M |
Date | Value |
---|---|
September 30, 2017 | -1.092M |
June 30, 2017 | -0.8326M |
March 31, 2017 | -0.7482M |
December 31, 2016 | -0.6392M |
September 30, 2016 | -0.165M |
June 30, 2016 | -0.0682M |
March 31, 2016 | -0.087M |
December 31, 2015 | -0.1035M |
September 30, 2015 | -0.1282M |
June 30, 2015 | -0.7597M |
March 31, 2015 | -0.6582M |
December 31, 2014 | -0.0918M |
September 30, 2014 | -0.1026M |
June 30, 2014 | -0.6388M |
March 31, 2014 | 0.0006M |
December 31, 2013 | -0.0004M |
September 30, 2013 | -0.0028M |
June 30, 2013 | 0.0034M |
March 31, 2013 | 0.0009M |
December 31, 2012 | -0.0157M |
September 30, 2012 | -0.0279M |
June 30, 2012 | -0.0401M |
March 31, 2012 | -0.0183M |
December 31, 2011 | -0.0761M |
September 30, 2011 | -0.0401M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-5.352M
Minimum
Mar 2022
-0.6915M
Maximum
Jun 2023
-2.434M
Average
-2.092M
Median
Dec 2019
Free Cash Flow (Quarterly) Benchmarks
Rimrock Gold Corp | -- |
Venus Concept Inc | -- |
Juva Life Inc | -0.9017M |
CEN Biotech Inc | 0.0527M |
Lucy Scientific Discovery Inc | -0.7395M |